Advances in the Correlation between Intestinal Microbiota and Breast Cancer Development — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Advances in the Correlation between Intestinal Microbiota and Breast Cancer Development
Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
,
Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
,
Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
1 Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
2 Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
3 Hainan Hospital Affiliated to The Hainan Medical College, Central Laboratory, Hainan General Hospital, Hainan Provincial Key Labor-atory of Cell and Molecular Genetic Translational Medicine, Hainan, China
The intestinal microbiota has a symbiotic relationship with humans. It participates in some important physiological activities in the human body and has an important impact on human health. It has become a hot topic of research by scientists in recent years. Among them, the research on the correlation between intestinal microbiota and cancer has increased rapidly. At present, the incidence rate of breast cancer is increasing, which seriously endangers the health of women. More and more studies have found that the occurrence of breast cancer is related to intestinal microbiota, and its possible mechanism inc ludes intestinal microbiota dysbiosis, estrogen metabolism changes, immun e regulation, and the participation of intestinal microbiota metabolites, etc. With the further development of high-throughput sequencing technology, th e research on the correlation between intestinal microbiota and breast cancer has become more in-depth, from a structural level confined to microorganisms to a more comprehensive system structure and function level. These research results provide a new research direction for the treatment of breast cancer. In order to further study the interaction between intestinal microbes and breast cancer, this article will comprehensively describe the intestinal microbiota and breast cancer from four aspects: intestinal microbial dysbiosis, altered estrogen metabolism, immune regulation, and intestinal microbial metabolites. It also reviews the application research of intestinal microbiota in breast cancer treatment, including the influence of intestinal microbiota on the effects of breast cancer radiotherapy and chemotherapy, probiotic therapy, and dietotherapy.
Qin, J., Li, R., Raes, J., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65. https://doi.org/10.1038/nature08821
Zhu, B., Wang, X. and Li, L. (2010) Human Gut Microbiome: The Second Genome of Human Body. Protein Cell, 1, 718-725. https://doi.org/10.1007/s13238-010-0093-z
Biragyn, A. and Ferrucci, L. (2018) Gut Dysbiosis: A Potential Link between Increased Cancer Risk in Ageing and Inflammaging. The Lancet Oncology, 19, e295-e304. https://doi.org/10.1016/S1470-2045(18)30095-0
Maynard, C.L., Elson, C.O., Hatton, R.D., et al. (2012) Reciprocal Interactions of the Intestinal Microbiota and Immune System. Nature, 489, 231-241. https://doi.org/10.1038/nature11551
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
Lacey, J.V., Kreimer, A.R., Buys, S.S., et al. (2009) Breast Cancer Epidemiology According to Recognized Breast Cancer Risk Factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer, 9, 84. https://doi.org/10.1186/1471-2407-9-84
Shapira, I., Sultan, K., Lee, A., et al. (2013) Evolving Concepts: How Diet and the Intestinal Microbiome Act as Modulators of Breast Malignancy. ISRN Oncology, 2013, Article ID: 693920. https://doi.org/10.1155/2013/693920
Mineli, E.B., Beghini, A.M., Vesentini, S., et al. (1990) Intestinal Microflora as an Alternative Metabolic Source of Estrogens in Women with Uterine Leiomyoma and Breast Cancer. Annals of the New York Academy of Sciences, 595, 473-479. https://doi.org/10.1111/j.1749-6632.1990.tb34337.x
Buchta Rosean, C., Bostic, R.R., Ferey, J.C.M., et al. (2019) Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer. Cancer Research, 79, 3662-3675. https://doi.org/10.1158/0008-5472.CAN-18-3464
Goedert, J.J., Jones, G., Hua, X., et al. (2015) Investigation of the Association between the Fecal Microbiota and Breast Cancer in Postmenopausal Women: A Population-Based Case-Control Pilot Study. Journal of the National Cancer Institute, 107, djv147. https://doi.org/10.1093/jnci/djv147
Kirkup, B., McKee, A., Makin, K., et al. (2019) Perturbation of the Gut Microbiota by Antibiotics Results in Accelerated Breast Tumour Growth and Metabolic Dysregulation. https://doi.org/10.1101/553602
Zhu, J., Liao, M., Yao, Z., et al. (2018) Breast Cancer in Postmenopausal Women Is Associated with an Altered Gut Metagenome. Microbiome, 6, 136. https://doi.org/10.1186/s40168-018-0515-3
Luu, T.H., Michel, C., Bard, J.M., et al. (2017) Intestinal Proportion of Blautia sp. Is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer. Nutrition and Cancer, 69, 267-275. https://doi.org/10.1080/01635581.2017.1263750
Wu, A.H., Tseng, C., Vigen, C., et al. (2020) Gut Microbiome Associations with Breast Cancer Risk Factors and Tumor Characteristics: A Pilot Study. Breast Cancer Research and Treatment, 182, 451-463. https://doi.org/10.1007/s10549-020-05702-6
Fernández, M.F., Iris, R.-P., Manuel, A.J., et al. (2018) Breast Cancer and Its Relationship with the Microbiota. International Journal of Environmental Research and Public Health, 15, 1747. https://doi.org/10.3390/ijerph15081747
Mikó, E., Vida, A. and Bai, P. (2016) Translational Aspects of the Microbiome-To Be Exploited. Cell Biology and Toxicology, 32, 153-156. https://doi.org/10.1007/s10565-016-9320-6
Tao, J., Li, S., Gan, R.Y., et al. (2020) Targeting Gut Microbiota with Dietary Components on Cancer: Effects and Potential Mechanisms of Action. Critical Reviews in Food Science and Nutrition, 60, 1025-1037. https://doi.org/10.1080/10408398.2018.1555789
Chen, J.Q. and Yager, J.D. (2004) Estrogen’s Effects on Mitochondrial Gene Expression: Mechanisms and Potential Contributions to Estrogen Carcinogenesis. Annals of the New York Academy of Sciences, 1028, 258-272. https://doi.org/10.1196/annals.1322.030
Samavat, H. and Kurzer, M.S. (2015) Estrogen Metabolism and Breast Cancer. Cancer Letters, 356, 231-243. https://doi.org/10.1016/j.canlet.2014.04.018
Key, T.J., Appleby, P.N., Reeves, G.K., et al. (2003) Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women. Journal of the National Cancer Institute, 95, 1218-1226. https://doi.org/10.1093/jnci/djg022
Sampson, J.N., Falk, R.T., Schairer, C., et al. (2017) Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. Cancer Research, 77, 918-925. https://doi.org/10.1158/0008-5472.CAN-16-1717
Adlercreutz, H., Pulkkinen, M.O., Hamalainen, E.K., et al. (1984) Studies on the Role of Intestinal Bacteria in Metabolism of Synthetic and Natural Steroid Hormones. Journal of Steroid Biochemistry, 20, 217-229. https://doi.org/10.1016/0022-4731(84)90208-5
Plottel, C.S. and Blaser, M.J. (2011) Microbiome and Malignancy. Cell Host & Microbe, 10, 324-335. https://doi.org/10.1016/j.chom.2011.10.003
Flores, R., Shi, J., Fuhrman, B., et al. (2012) Fecal Microbial Determinants of Fecal and Systemic Estrogens and Estrogen Metabolites: A Cross-Sectional Study. Journal of Translational Medicine, 10, Article No. 253. https://doi.org/10.1186/1479-5876-10-253
Fuhrman, B.J., Feigelson, H.S., Flores, R., et al. (2014) Associations of the Fecal Microbiome with Urinary Estrogens and Estrogen Metabolites in Postmenopausal Women. The Journal of Clinical Endocrinology and Metabolism, 99, 4632-4640. https://doi.org/10.1210/jc.2014-2222
Baker, J.M., Al-Nakkash, L. and Herbst-Kralovetz, M.M. (2017) Estrogen-Gut Microbiome Axis: Physiological and Clinical Implications. Maturitas, 103, 45-53. https://doi.org/10.1016/j.maturitas.2017.06.025
Yang, J., Tan, Q., Fu, Q., et al. (2017) Gastrointestinal Microbiome and Breast Cancer: Correlations, Mechanisms and Potential Clinical Implications. Breast Cancer, 24, 220-228. https://doi.org/10.1007/s12282-016-0734-z
Dabek, M., McCrae, S.I., Stevens, V.J., et al. (2008) Distribution of Beta-Glucosidase and Beta-Glucuronidase Activity and of Beta-Glucuronidase Gene Gus in Human Colonic Bacteria. FEMS Microbiology Ecology, 66, 487-495. https://doi.org/10.1111/j.1574-6941.2008.00520.x
McIntosh, F.M., Maison, N., Holtrop, G., et al. (2012) Phylogenetic Distribution of Genes Encoding β-Glucuronidase Activity in Human Colonic Bacteria and the Impact of Diet on Faecal Glycosidase Activities. Environmental Microbiology, 14, 1876-1887. https://doi.org/10.1111/j.1462-2920.2012.02711.x
Gloux, K., Berteau, O., El Oumami, H., et al. (2011) A Metagenomic β-Glucuronidase Uncovers a Core Adaptive Function of the Human Intestinal Microbiome. Proceedings of the National Academy of Sciences of the United States of America, 108, 4539-4546. https://doi.org/10.1073/pnas.1000066107
Crusz, S.M. and Balkwill, F.R. (2015) Inflammation and Cancer: Advances and New Agents. Nature Reviews Clinical Oncology, 12, 584-596. https://doi.org/10.1038/nrclinonc.2015.105
Vogtmann, E. and Goedert, J.J. (2016) Epidemiologic Studies of the Human Microbiome and Cancer. British Journal of Cancer, 114, 237-242. https://doi.org/10.1038/bjc.2015.465
Chassaing, B., Kumar, M., Baker, M.T., et al. (2014) Mammalian Gut Immunity. Biomedical Journal, 37, 246-258. https://doi.org/10.4103/2319-4170.130922
Buchta Rosean, C.M. and Rutkowski, M.R. (2017) The Influence of the Commensal Microbiota on Distal Tumor-Promoting Inflammation. Seminars in Immunology, 32, 62-73. https://doi.org/10.1016/j.smim.2017.06.002
Xuan, C., Shamonki, J.M., Chung, A., et al. (2014) Microbial Dysbiosis Is Associated with Human Breast Cancer. PLoS ONE, 9, e83744. https://doi.org/10.1371/journal.pone.0083744
Lakritz, J.R., Poutahidis, T., Levkovich, T., et al. (2014) Beneficial Bacteria Stimulate Host Immune Cells to Counteract Dietary and Genetic Predisposition to Mammary Cancer in Mice. International Journal of Cancer, 135, 529-540. https://doi.org/10.1002/ijc.28702
Peterson, D.A., McNulty, N.P., Guruge, J.L., et al. (2007) IgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis. Cell Host & Microbe, 2, 328-339. https://doi.org/10.1016/j.chom.2007.09.013
Goedert, J.J., Hua, X., Bielecka, A., et al. (2018) Postmenopausal Breast Cancer and Oestrogen Associations with the IgA-Coated and IgA-Noncoated Faecal Microbiota. British Journal of Cancer, 118, 471-479. https://doi.org/10.1038/bjc.2017.435
Sun, J., Furio, L., Mecheri, R., et al. (2015) Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. Immunity, 43, 304-317. https://doi.org/10.1016/j.immuni.2015.07.013
Chace, D. (2015) Turning Off Breast Cancer: A Personalized Approach to Nutrition and Detoxification in Prevention and Healing. Skyhorse Publishing, Inc., New York.
Rao, V.P., Poutahidis, T., Ge, Z., et al. (2006) Innate Immune Inflammatory Response against Enteric Bacteria Helicobacter hepaticus Induces Mammary Adenocarcinoma in Mice. Cancer Research, 66, 7395-7400. https://doi.org/10.1158/0008-5472.CAN-06-0558
Vétizou, M., Pitt, J.M., Daillère, R., et al. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084. https://doi.org/10.1126/science.aad1329
Gopalakrishnan, V., Spencer, C.N., Nezi, L., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103. https://doi.org/10.1126/science.aan4236
Sivan, A., Corrales, L., Hubert, N., et al. (2015) Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti-PD-L1 Efficacy. Science, 350, 1084-1089. https://doi.org/10.1126/science.aac4255
Routy, B., Le Chatelier, E., Derosa, L., et al. (2018) Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors. Science, 359, 91-97. https://doi.org/10.1126/science.aan3706
Rossi, T., Vergara, D., Fanini, F., et al. (2020) Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International Journal of Molecular Sciences, 21, 5786. https://doi.org/10.3390/ijms21165786
Mikó, E., Kovács, T., Sebo, é., et al. (2019) Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells, 8, 293. https://doi.org/10.3390/cells8040293
Thirunavukkarasan, M., Wang, C., Rao, A., et al. (2017) Short-Chain Fatty Acid Receptors Inhibit Invasive Phenotypes in Breast Cancer Cells. PLoS ONE, 12, e0186334. https://doi.org/10.1371/journal.pone.0186334
Kiweler, N., Wünsch, D., Wirth, M., et al. (2020) Histone Deacetylase Inhibitors Dysregulate DNA Repair Proteins and Antagonize Metastasis-Associated Processes. Journal of Cancer Research and Clinical Oncology, 146, 343-356. https://doi.org/10.1007/s00432-019-03118-4
Salimi, V., Shahsavari, Z., Safizadeh, B., et al. (2017) Sodium Butyrate Promotes Apoptosis in Breast Cancer Cells through Reactive Oxygen Species (ROS) Formation and Mitochondrial Impairment. Lipids in Health and Disease, 16, Article No. 208. https://doi.org/10.1186/s12944-017-0593-4
Ashida, H., Ogawa, M., Kim, M., et al. (2011) Bacteria and Host Interactions in the Gut Epithelial Barrier. Nature Chemical Biology, 8, 36-45. https://doi.org/10.1038/nchembio.741
Rubin, R. (2019) High-Fiber Diet Might Protect against Range of Conditions. JAMA, 321, 1653-1655. https://doi.org/10.1001/jama.2019.2539
Vital, M., Howe, A.C. and Tiedje, J.M. (2014) Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data. mBio, 5, e00889. https://doi.org/10.1128/mBio.00889-14
Zhao, L., Yang, R., Cheng, L., et al. (2011) LPS-Induced Epithelial-Mesenchymal Transition of Intrahepatic Biliary Epithelial Cells. Journal of Surgical Research, 171, 819-825. https://doi.org/10.1016/j.jss.2010.04.059
Kim, Y., Lee, E.J., Jang, H.K., et al. (2016) Statin Pretreatment Inhibits the Lipopolysaccharide-Induced Epithelial-Mesenchymal Transition via the Downregulation of Toll-Like Receptor 4 and Nuclear Factor-κB in Human Biliary Epithelial Cells. Journal of Gastroenterology and Hepatology, 31, 1220-1228. https://doi.org/10.1111/jgh.13230
Zhu, G.H.Q., Huang, Y., Zheng, W., Hua, J., Yang, S., Zhuang, J., Wang, J. and Ye, J. (2016) Lipopolysaccharide Increases the Release of VEGF-C That Enhances Cell Motility and Promotes Lymphangiogenesis and Lymphatic Metastasis through the TLR4-NF-kB/JNK Pathways in Colorectal Cancer. Oncotarget, 7, 73711-73724. https://doi.org/10.18632/oncotarget.12449
Costarelli, V. and Sanders, T.A. (2002) Plasma Deoxycholic Acid Concentration Is Elevated in Postmenopausal Women with Newly Diagnosed Breast Cancer. European Journal of Clinical Nutrition, 56, 925-927. https://doi.org/10.1038/sj.ejcn.1601396
Zhu, Y., Zhu, M. and Lance, P. (2012) Stromal COX-2 Signaling Activated by Deoxycholic Acid Mediates Proliferation and Invasiveness of Colorectal Epithelial Cancer Cells. Biochemical and Biophysical Research Communications, 425, 607-612. https://doi.org/10.1016/j.bbrc.2012.07.137
Mikó, E., Vida, A., Kovács, T., et al. (2018) Lithocholic Acid, a Bacterial Metabolite Reduces Breast Cancer Cell Proliferation and Aggressiveness. Biochimica et Biophysica Acta—Bioenergetics, 1859, 958-974. https://doi.org/10.1016/j.bbabio.2018.04.002
Kovács, T., Mikó, E., Vida, A., et al. (2019) Cadaverine, a Metabolite of the Microbiome, Reduces Breast Cancer Aggressiveness through Trace Amino Acid Receptors. Scientific Reports, 9, Article No. 1300. https://doi.org/10.1038/s41598-018-37664-7
Zhu, Q., Jin, L., Casero, R.A., et al. (2012) Role of Ornithine Decarboxylase in Regulation of Estrogen Receptor Alpha Expression and Growth in Human Breast Cancer Cells. Breast Cancer Research and Treatment, 136, 57-66. https://doi.org/10.1007/s10549-012-2235-x
Ward, H.A. and Kuhnle, G.G. (2010) Phytoestrogen Consumption and Association with Breast, Prostate and Colorectal Cancer in EPIC Norfolk. Archives of Biochemistry and Biophysics, 501, 170-175. https://doi.org/10.1016/j.abb.2010.05.018
Milder, I.E., Kuijsten, A., Arts, I.C., et al. (2007) Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population. Journal of Nutrition, 137, 1266-1271. https://doi.org/10.1093/jn/137.5.1266
Pietinen, P., Stumpf, K., Mannisto, S., et al. (2001) Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland. Cancer Epidemiology, Biomarkers & Prevention, 10, 339-344.
Saarinen, N.M., Warri, A., Airio, M., et al. (2007) Role of Dietary Lignans in the Reduction of Breast Cancer Risk. Molecular Nutrition & Food Research, 51, 857-866. https://doi.org/10.1002/mnfr.200600240
Cotterchio, M., Boucher, B.A., Kreiger, N., et al. (2008) Dietary Phytoestrogen Intake—Lignans and Isoflavones—And Breast Cancer Risk (Canada). Cancer Causes & Control, 19, 259-272. https://doi.org/10.1007/s10552-007-9089-2
Parida, S. and Sharma, D. (2019) The Microbiome-Estrogen Connection and Breast Cancer Risk. Cells, 8, 1642. https://doi.org/10.3390/cells8121642
Roy, S. and Trinchieri, G. (2017) Microbiota: A Key Orchestrator of Cancer Therapy. Nature Reviews Cancer, 17, 271-285. https://doi.org/10.1038/nrc.2017.13
Alexander, J.L., Wilson, I.D., Teare, J., et al. (2017) Gut Microbiota Modulation of Chemotherapy Efficacy and Toxicity. Nature Reviews Gastroenterology & Hepatology, 14, 356-365. https://doi.org/10.1038/nrgastro.2017.20
Haiser, H.J. and Turnbaugh, P.J. (2013) Developing a Metagenomic View of Xenobiotic Metabolism. Pharmacological Research, 69, 21-31. https://doi.org/10.1016/j.phrs.2012.07.009
Lehouritis, P., Cummins, J., Stanton, M., et al. (2015) Local Bacteria Affect the Efficacy of Chemotherapeutic Drugs. Scientific Reports, 5, Article No. 14554. https://doi.org/10.1038/srep14554
Maier, I., Berry, D.M. and Schiestl, R.H. (2014) Intestinal Microbiota Reduces Genotoxic Endpoints Induced by High-Energy Protons. Radiation Research, 181, 45-53. https://doi.org/10.1667/RR13352.1
Touchefeu, Y., Montassier, E., Nieman, K., et al. (2014) Systematic Review: The Role of the Gut Microbiota in Chemotherapy- or Radiation-Induced Gastrointestinal Mucositis—Current Evidence and Potential Clinical Applications. Alimentary Pharmacology & Therapeutics, 40, 409-421. https://doi.org/10.1111/apt.12878
Yazdi, M.H., Soltan Dallal, M.M., Hassan, Z.M., et al. (2010) Oral Administration of Lactobacillus acidophilus Induces IL-12 Production in Spleen Cell Culture of BALB/c Mice Bearing Transplanted Breast Tumour. British Journal of Nutrition, 104, 227-232. https://doi.org/10.1017/S0007114510000516
Hassan, Z., Mustafa, S., Rahim, R.A., et al. (2016) Anti-Breast Cancer Effects of Live, Heat-Killed and Cytoplasmic Fractions of Enterococcus faecalis and Staphylococcus hominis Isolated from Human Breast Milk. In Vitro Cellular & Developmental Biology—Animal, 52, 337-348. https://doi.org/10.1007/s11626-015-9978-8
Toi, M., Hirota, S., Tomotaki, A., et al. (2013) Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-Control Study. Current Nutrition & Food Science, 9, 194-200. https://doi.org/10.2174/15734013113099990001
Newman, T.M., Vitolins, M.Z. and Cook, K.L. (2019) From the Table to the Tumor: The Role of Mediterranean and Western Dietary Patterns in Shifting Microbial-Mediated Signaling to Impact Breast Cancer Risk. Nutrients, 11, 2565. https://doi.org/10.3390/nu11112565
Xue, M., Ji, X., Liang, H., et al. (2018) The Effect of Fucoidan on Intestinal Flora and Intestinal Barrier Function in Rats with Breast Cancer. Food & Function, 9, 1214-1223. https://doi.org/10.1039/C7FO01677H
Hullar, M.A., Burnett-Hartman, A.N. and Lampe, J.W. (2014) Gut Microbes, Diet, and Cancer. Cancer Treatment and Research, 159, 377-399. https://doi.org/10.1007/978-3-642-38007-5_22